DK0710111T3 - Hormonal agent for the treatment of acne and its use - Google Patents

Hormonal agent for the treatment of acne and its use

Info

Publication number
DK0710111T3
DK0710111T3 DK94916880T DK94916880T DK0710111T3 DK 0710111 T3 DK0710111 T3 DK 0710111T3 DK 94916880 T DK94916880 T DK 94916880T DK 94916880 T DK94916880 T DK 94916880T DK 0710111 T3 DK0710111 T3 DK 0710111T3
Authority
DK
Denmark
Prior art keywords
hormonal
hormone
daily units
component
hormone component
Prior art date
Application number
DK94916880T
Other languages
Danish (da)
Inventor
Marika Dr Med Ehrlich
Herbert Prof Dr Kuhl
Original Assignee
Marika Dr Med Ehrlich
Herbert Prof Dr Kuhl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0710111(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marika Dr Med Ehrlich, Herbert Prof Dr Kuhl filed Critical Marika Dr Med Ehrlich
Application granted granted Critical
Publication of DK0710111T3 publication Critical patent/DK0710111T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Abstract

A hormonal agent for the treatment of acne with two spatially separated hormonal components fitted separately in a packaging unit and intended for administration sequentially in time, consisting of a number of hormonal daily units arranged spatially separately in and individually removable from the packaging unit, a first hormonal component essentially containing as the hormonal active agent only an oestrogen preparation causing an increase in the sex hormone-binding globulin (SHBG) and the second hormone component containing an oestrogen and an anti-androgen preparation in combination, characterized in that the total number of daily units is equal to the total number of days in the desired cycle, in that the first hormone component comprises 5 to 14 and the second hormone component 23 to 14 daily units, and in that the number of daily units of the first hormone component is smaller than that of the second hormone component. The invention also concerns the use of this hormonal agent.
DK94916880T 1993-07-01 1994-06-03 Hormonal agent for the treatment of acne and its use DK0710111T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4321957A DE4321957C2 (en) 1993-07-01 1993-07-01 Use of a hormonal agent to treat acne
PCT/DE1994/000629 WO1995001180A1 (en) 1993-07-01 1994-06-03 Hormonal agent for the treatment of acne and its use

Publications (1)

Publication Number Publication Date
DK0710111T3 true DK0710111T3 (en) 2001-12-10

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916880T DK0710111T3 (en) 1993-07-01 1994-06-03 Hormonal agent for the treatment of acne and its use

Country Status (14)

Country Link
EP (1) EP0710111B1 (en)
JP (1) JPH09500112A (en)
AT (1) ATE205716T1 (en)
AU (1) AU695894B2 (en)
BR (1) BR9407340A (en)
CA (1) CA2166121A1 (en)
DE (2) DE4321957C2 (en)
DK (1) DK0710111T3 (en)
ES (1) ES2164103T3 (en)
HU (1) HUT73234A (en)
NO (1) NO308586B1 (en)
PT (1) PT710111E (en)
UA (1) UA43337C2 (en)
WO (1) WO1995001180A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (en) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonal agent for the treatment of the skin
EP1048673A4 (en) * 1997-12-26 2002-10-25 Mochida Pharm Co Ltd Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026670A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102004026671A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Dosage form for hormonal contraception
DE102004026679A1 (en) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102006003508A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Use of hormone combination of estrogen from ethinyl estradiol and metabolites of chlormadinone acetate, with chlormadione acetate as gestagen components, for producing medicament e.g. for preventing menstruation cycle-dependent mood
DE102006003509A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Drug delivery system, for hormonal contraception, comprises hormone-containing daily unit, which exhibits estrogen from ethinyl estradiol and estradiol and from metabolite of the chlormadinone acetate optionally with gestagen component

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79447B (en) * 1982-12-31 1984-10-30 Mortimer Christopher H Dr
DE3442857A1 (en) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Composition for the treatment of androgenisation symptoms in women
DE3916112A1 (en) * 1989-05-16 1990-11-22 Schering Ag DIHYDROSPIRORENONE AS AN ANTIANDROGEN
DE4104385C1 (en) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
ATE205716T1 (en) 2001-10-15
EP0710111B1 (en) 2001-09-19
AU695894B2 (en) 1998-08-27
EP0710111A1 (en) 1996-05-08
JPH09500112A (en) 1997-01-07
DE59409869D1 (en) 2001-10-25
BR9407340A (en) 1996-10-08
NO308586B1 (en) 2000-10-02
WO1995001180A1 (en) 1995-01-12
ES2164103T3 (en) 2002-02-16
UA43337C2 (en) 2001-12-17
DE4321957A1 (en) 1995-01-12
PT710111E (en) 2002-02-28
CA2166121A1 (en) 1995-01-12
HUT73234A (en) 1996-07-29
HU9503770D0 (en) 1996-02-28
AU6840894A (en) 1995-01-24
DE4321957C2 (en) 1995-09-28
NO955347L (en) 1995-12-29
NO955347D0 (en) 1995-12-29

Similar Documents

Publication Publication Date Title
AU1255002A (en) Delayed-release pharmaceutical formulations
ATE296612T1 (en) ACTIVE INGREDIENTS FOR THE TREATMENT OF SENIL XEROSIS AND PREPARATIONS
DE69432752D1 (en) COMPOSITION FOR SUBSTITUTION THERAPY THAT CONTAINS AT LEAST ONE PROGESTOGEN AND AT LEAST ONE OESTROGEN
ES2140658T3 (en) TRANSDERMIC THERAPEUTIC SYSTEMS CONTAINING SEXUAL STEROIDS.
AR010385A1 (en) PROPIOPHENONE-DERIVED COMPOUND, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE OF SUCH COMPOUND.
BR9408513A (en) Agent and method for hormonal contraception and / or for the treatment of acne
HUP0100801A2 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intented to reduce hyperglycaemia
PL315114A1 (en) Compounds exhibiting properties of releasing growth hormones
DK0705244T3 (en) Nitro-amino acid disulfide for the treatment of diseases of the cardiovascular system
DE69101080D1 (en) Dietary fiber, process and physiological active composition that contains it as an active ingredient.
ATE279919T1 (en) AGMATINE FOR THE TREATMENT OF NEUROPATHIC PAIN
MY106938A (en) Method of treating premature ejaculation using sertraline
DK0668755T3 (en) Generating device having encapsulated excipients
ATE171873T1 (en) ANTIGLUCOCORTICOID STEROIDS FOR THE TREATMENT OF ANXIETY DISORDERS
DK0663835T3 (en) Use of parathormone, its biologically active fragments and related peptides for the treatment of pregnancy
DK0710111T3 (en) Hormonal agent for the treatment of acne and its use
FI962550A0 (en) Deuterated active substances for transdermal use
ES2100680T3 (en) COMPOSITION FOR HAIR TREATMENT.
TNSN96016A1 (en) USE OF PHENYLCYCLOHEXYLCARBOXAMIDES
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
DE60122943D1 (en) COMPOSITION CONTAINING OESTROGEN OR OTHER HORMONE WITH ASCORBATE, LYSIN AND PROLIN ETC
MXPA05012655A (en) Pure d-(17 alpha)-13-ethyl -17-hydroxy-18, 19-dinorpregn-4- ene-20- yne-3-one -3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers.
IT1269827B (en) Lidocaine bicarbonate, its pharmaceutical use and compositions containing it
GR1003059B (en) Balsamine - olive-oil: hair-regrowth product.